Quantum Pharma PLC (LSE:QP.) - Share price - Overview

Stock Report

Quantum Pharma PLC QP.

Last Price
GBX72.13

Day Change
-0.25|-0.35%

As of 18/08/2017
17:20:41 BST | GBX
Minimum 15 Minutes Delay.

Last Close72.38p
Day Range71.02 - 74.00
Mkt Cap122.40Mil
52-Wk Range32.75 - 91.70
Yield %1.39
ISINGB00BRTL8Q42
Volume583,983
P/E98.00
P/S1.09
P/CF26.66

Share Price

Total Returns 18/08/2017

 Chg (%)  
More ...
Quantum Pharma PLC30.54 
FTSE 100 TR GBP0.60
 
Financials
201520162017
More ...
Income Statement
Turnover61.7269.2388.77
Operating Profit6.677.49-9.85
Net Profit0.725.91-9.06
Reported EPS0.564.50-6.70
Balance Sheet
Current Assets21.3322.8427.12
Non Current Assets61.2184.5063.70
Total Assets82.54107.3590.82
Current Liabilities16.3928.1825.89
Total Liabilities31.8251.8444.21
Total Equity50.7255.5146.61
Cash Flow
Operating Cash Flow2.92-1.954.03
Net Change in Cash1.59-1.633.70
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/11/2016PurchaseMr. Ian Johnson34.0058,82420,000.00
11/11/2016PurchaseDr. John Brown34.0073,52925,000.00
11/11/2016PurchaseChris Rigg34.00147,05950,000.00

Company Profile

Quantum Pharma PLC is a service-led niche pharmaceutical developer, manufacturer, and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital, and homecare markets.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

861 of 1846 Companies

Index

FTSE AIM All Share

Outlook

(09/08/2017) "...group adjusted EBITDA for the half year ended 31 July 2017 is expected to be in line with management expectations"

Next Event 22/08/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0013.8016.61
Div Yld (E)0.004.014.19
PEG (E)0.000.631.11
ROCE3.75183.00207.14
Op Mrgn0.19-6.01-99.47
EPS Grwth0.0028.7723.71
Dividends
PreviousLatest
More ...
Record Date30/10/1521/10/16
Ex-Div29/10/1520/10/16
Paid20/11/1507/11/16
Amnt0.501.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Johnson
Chief Executive OfficerChris Rigg
Chief Financial OfficerGed Murray
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.